Podcasts about ganz

Innenministerin Nancy Faeser stellt sich endlich den Fragen der Parlamentarier. Ganz kann sie die Vorwürfe aber nicht aus der Welt schaffen. Außerdem: Wie sich bei den Vereinten Nationen gerade die Gewichte der globalen Politik verschieben (18:30)Jasper BarenbergDirekter Link zur Audiodatei

Aufschlag, Rücken, IBU.", meint Tobi und denkt Patrick Mouratoglou sei daran schuld. Ganz so isses nun nicht, warnen Henrike und Daniel und verhindern damit, dass wir bei den Tennisproleten ihm am Ende auch noch die Schuld für das Scheitern des Davis Cup geben. Ganz schön was los in der Woche nach den US Open. Die Tennisproleten informieren.

Ihr könnt mit Nachrichten kein Geld verdienen! Selbst wenn ihr völlig korrekt analysiert und interpretiert: Ihr könnt mit Nachrichten kein Geld verdienen - eine steile These, die ich einfach mal so heraushaue, obwohl ich 15 Jahre lang beinahe ausschließlich mit Nachrichten mein Geld verdient habe. Ganz entscheidend ist hier aber der Zeitfaktor. Wie das gemeint ist, werde ich in dieser Folge erläutern. Ich hoffe dem einen oder der anderen erspart dieser Podcast ein paar Euros Verlust. ► Hier zum Webinar am 19. September anmelden: https://www.lars-erichsen.de/webinar ► Schau Dir hier die neue Aktion der Rendite-Spezialisten an: https://www.rendite-spezialisten.de/aktion  
► TIPP: Sichere Dir wöchentlich meine Tipps zu Gold, Aktien, ETFs & Co. – 100% gratis: https://erichsen-report.de/ Viel Freude beim Anhören. Über eine Bewertung und einen Kommentar freue ich mich sehr. Jede Bewertung ist wichtig. Denn sie hilft dabei den Podcast bekannter zu machen. Damit noch mehr Menschen verstehen, wie sie ihr Geld mit Rendite anlegen können.  ► Mein YouTube-Kanal: http://youtube.com/ErichsenGeld 
 ► Folge meinem LinkedIn-Account: https://www.linkedin.com/in/erichsenlars/  
► Folge mir bei Facebook: https://www.facebook.com/ErichsenGeld/  
► Folge meinem Instagram-Account: https://www.instagram.com/erichsenlars Die verwendete Musik wurde unter www.soundtaxi.net lizensiert.  Quelle der Audio-Zitate: YouTube-Kanal: Apple Special Event 2014 - Apple Watch Introduction
 https://www.youtube.com/watch?v=bdyVH5LqneU Bürgergeld: the unofficial AppleKeynotes channel Abgerufen am: 11.09.2023 Ein wichtiger abschließender Hinweis: Aus rechtlichen Gründen darf ich keine individuelle Einzelberatung geben. Meine geäußerte Meinung stellt keinerlei Aufforderung zum Handeln dar. Sie ist keine Aufforderung zum Kauf oder Verkauf von Wertpapieren.

„Die Sorge um globale Erwärmung ist eine totale Erfindung“: Der Nobelpreisträger John Clauser steht seit Kurzem im Rampenlicht, weil er die vorherrschenden Klimamodelle infrage stellt. Sie ignorieren seiner Meinung nach eine Schlüsselvariable. Web: https://www.epochtimes.de Probeabo der Epoch Times Wochenzeitung: https://bit.ly/EpochProbeabo Twitter: https://twitter.com/EpochTimesDE YouTube: https://www.youtube.com/channel/UC81ACRSbWNgmnVSK6M1p_Ug Telegram: https://t.me/epochtimesde Gettr: https://gettr.com/user/epochtimesde Facebook: https://www.facebook.com/EpochTimesWelt/ Unseren Podcast finden Sie unter anderem auch hier: iTunes: https://podcasts.apple.com/at/podcast/etdpodcast/id1496589910 Spotify: https://open.spotify.com/show/277zmVduHgYooQyFIxPH97 Unterstützen Sie unabhängigen Journalismus: Per Paypal: http://bit.ly/SpendenEpochTimesDeutsch Per Banküberweisung (Epoch Times Europe GmbH, IBAN: DE 2110 0700 2405 2550 5400, BIC/SWIFT: DEUTDEDBBER, Verwendungszweck: Spenden) Vielen Dank! (c) 2023 Epoch Times

"Ingathering Sunday: Bring in the People and the Waters!" Sunday, September 10, 10:50 am, 2023 This Sunday is opening Sunday! Church may serve as a place to "Remember" or to get an understanding of what it is to be human. Bring any water from areas you went this summer (even if it was from your backyard spigot or a nearby park). If you don't, we will have water accessible, and we look forward to your offering of what you bring from the summer into community -- what wisdom, what joy, what grief, what sense of possibilities or yearnings -- all of it presented into the year we begin together. Rev. Vanessa Rush Southern, Senior Minister; Rev. Laura Shennum, Minister of Congregational Life; Rev. Seanan Fong, Community Minister; Dennis Adams, Worship Associate; Lucy Smith, Board of Trustees; Reiko Oda Lane, Organist; UUSF Choir led by Mark Sumner, Music Director; Nancy Munn, Soloist; Wm. García Ganz, Pianist Shulee Ong, Camera; Jackson Munn, Camera; Santana Gonzalez-Gomez, Live Chat Moderator; Jonathan Silk, Communications Director; Amy Kelly, Flowers; Linda Messner, Head Usher

Wo stehe ich selbst als Mama oder Papa eigentlich auf meiner Prio-Liste von Personen, die mir wichtig sind? Wie siehts mit meiner Selbstliebe aus? Wie ich meine eigenen Bedürfnisse mit denen meines Kindes synchronisieren kann, bespreche ich mit Dr. med. Miriam Kirchhof, die du vielleicht schon aus Podcastfolge 249 kennst: Selbstfürsorge und Mama Care https://die-friedliche-geburt.de/2022/08/21/249-selbstfuersorge-und-mama-care-interview-mit-dr-miriam-haerlein/ Miriam hat gerade erst ihr Buch „Einfach gesund Mama sein. Mind-Body-Medizin für die natürliche Balance“ + Mama Care to go APP & Toolbox für die ersten 1000 Tage mit Kind als einen Gesundheitskompass zur bedürfnisorientierten Mutterschaft veröffentlicht und gibt uns spannende Einblicke in die neuronalen und hormonellen Veränderungen beim Mamawerden. Sogar das Gehirn werdender Papas und Co-Mamas kann sich verändern, während Bindung zum Baby aufgebaut wird. In diesem Interview erfährst du, wie: - sich Strukturen im Gehirn schon in der Schwangerschaft verändern - das Hormon Oxytocin für die Bindung von Mama/Papa und Baby wirkt - Bindung und Fürsorge hormonell zusammenhängen - geteilte Empathie und geteilte Bedürfnisbefriedigung machbar sind - wir Bindung als Ressource für uns Eltern nutzen können, ohne uns zu verlieren Du kannst uns wieder sehr gerne auf YouTube zusehen https://youtu.be/O1-VLe1btCc Schreibe mir sehr gerne auf Instagram, wie du auf deine Bedürfnisse im stressigen Familienalltag achtest https://www.instagram.com/die.friedliche.geburt/?hl=de Alle Infos zu Miriam auf ihrer Website: https://drmiriamkirchhof.com & auf Instagram: https://www.instagram.com/mamacare_dr_miriam_kirchhof/ Miriams Buch-Tipp: Lieselotte Ahnert: „Wieviel Mutter braucht ein Kind?“ (2020) Ganz viele wertvolle Einsichten mit dieser Podcastfolge! Alles Liebe Deine Kristin

There was time during the early 70's when the field of oncology began to take hold where the singular focus was to extend the patient's life. In this ASCO Education podcast, our guest was one of the first to challenge that notion and rethink methods that focused the patient's QUALITY of life. Dr. Patricia Ganz joins us to describe her transition from cardiology to oncology (6:00), the moment she went beyond treating the disease and began thinking about treating the WHOLE patient (10:06) and the joy of the increasing numbers of patients who survive cancer (21:47).  Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Patricia Ganz: Leadership - Intrinsic LifeSciences  Stock and Other Ownership Interests - xenon pharma,  Intrinsic LifeSciences, Silarus Therapeutics, Disc Medicine, Teva,  Novartis, Merck. Johnson & Johnson, Pfizer, GlaxoSmithKline, Abbott Laboratories Consulting or Advisory Role - Global Blood Therapeutics, GSK, Ionis, akebia, Rockwell Medical Technologies, Disc Medicine, InformedDNA, Blue Note Therapeutics, Grail Patents, Royalties, Other Intellectual Property - related to iron metabolism and the anemia of chronic disease, Up-to-Date royalties for section editor on survivorship Resources If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT  Disclosures for this podcast are listed on the podcast page.   Pat Loehrer: Welcome to Oncology, Etc., an ASCO Education Podcast. I'm Pat Loehrer, Director of Global Oncology and Health Equity at Indiana University.  Dave Johnson: And I'm Dave Johnson, a Medical Oncologist at the University of Texas Southwestern in Dallas. If you're a regular listener to our podcast, welcome back. If you're new to Oncology, Etc., the purpose of the podcast is to introduce listeners to interesting and inspirational people and topics in and outside the world of oncology. Pat Loehrer: The field of oncology is relatively new. The first person treated with chemotherapy was in the 1940s. Medical oncology was just recognized as a specialty during the 1970s. And while cancer was considered by most people to be a death sentence, a steady growth of researchers sought to find cures. And they did for many cancers. But sometimes these treatments came at a cost. Our next guest challenged the notion that the singular focus of oncology is to extend the patient's duration of life. She asked whether an oncologist should also focus on addressing the patient's quality of life.  Dave Johnson: The doctor asking that question went to UCLA Medical School, initially planning to study cardiology. However, a chance encounter with a young, dynamic oncologist who had started a clinical cancer ward sparked her interest in the nascent field of oncology. She witnessed advances in cancer treatment that seemingly took it from that inevitable death sentence to a potentially curable disease. She also recognized early on that when it came to cancer, a doctor must take care of the whole patient and not just the disease.  From that point forward, our guest has had a storied career and an incredible impact on the world of cancer care. When initially offered a position at the West LA VA Medical Center, she saw it as an opportunity to advance the field of palliative care for patients with cancer. This proved to be one of her first opportunities to develop a program that incorporated a focus on quality of life into the management of cancer. Her work also focused on mental, dietary, physical, and emotional services to the long-term survivors of cancer.  That career path has led to many accomplishments and numerous accolades for our guest. She is a founding member of the National Coalition for Cancer Survivorship, served as the 2004 Co-chair of ASCO's Survivorship Task Force, and currently directs UCLA's Cancer Survivorship Center of Excellence, funded in part from a grant from Livestrong. Our guest is Dr. Patricia Ganz. Dr. Patricia Ganz: It's great to be with both of you today. Dave Johnson: We always like to ask our guests a little about their background, where they grew up, a little about their family. Dr. Patricia Ganz: Yes. I grew up in the city of Beverly Hills where my parents moved when I was about five years old because of the educational system. Unlike parts of the East Coast, we didn't have very many private schools in Los Angeles, and so public education was very good in California at that time. So I had a good launch and had a wonderful opportunity that many people didn't have at that time to grow up in a comfortable setting. Dave Johnson: Tell us about your mom. I understand she was a businesswoman, correct? Dr. Patricia Ganz: Yes, actually, my parents got married when my mom was 19 and my dad was 21. He was in medical school at the University of Michigan. His father and mother weren't too happy with him getting married before he could support a wife. But she worked in a family business in the wholesale produce business in Detroit. One of six children, she was very involved with her family in the business. And they were married, and then World War II started, my father was a physician in the military, so she worked in the family business during the war. After finally having children and growing up and being in Beverly Hills, she sat back and was a homemaker, but she was always a bit restless and was always looking for something to do. So wound up several years later, when I was in my early teens, starting a business with one of my uncles, an automobile parts business. They ultimately sold it out to a big company that bought it out.  Pat Loehrer: Where did your father serve in World War II? Dr. Patricia Ganz: He was actually D-Day Plus 21. He was in Wales during the war. They had to be stationed and moved down into the south before he was deployed. I have my parents' correspondence and letters from the war. He liberated some of the camps. Actually, as I have learned about the trauma of cancer and post-traumatic stress that happens in so many people, our military veterans, most recently, I think he had post-traumatic stress. He didn't talk very much about it, but I think liberating the camps, being overseas during that time, as it was for that silent generation, was very profound in terms of their activities.   He wound up practicing medicine, and Los Angeles had a practice in industrial medicine, and it was a comfortable life. He would work early in the morning till maybe three or four in the afternoon and then go to the gym, there were moonlighting physicians who worked in the practice. But I kind of saw an easy kind of medicine, and he was always very encouraging and wanted me to go into medicine -- that I could be an ophthalmologist or a radiologist, good job for a woman. But I didn't really see the tough life of some of the internists and other people who were really working more 24/7, taking care of patients in the way medicine used to be practiced. Dave Johnson: Yeah. So you were interested in, early in your career, in cardiology. Could you tell us about that, and then a little bit more about the transition to oncology?  Dr. Patricia Ganz: I went away to college, I went to Harvard Radcliffe and I came home during the summers. And was interested in doing something during the summer so I actually in a pediatric cardiology research laboratory as a volunteer at UCLA for a couple of summers between my freshman and sophomore year then my sophomore and junior year. And then I actually got a California Heart Association Fellowship between my junior and senior year in college.  And this pediatric cardiology lab was very interesting. They were starting to give ketamine, it had an identification number, it wasn't called ketamine. But they were giving it to children in the cardiac cath lab and then were very worried about whether it would interfere with measuring the pressures in the heart. So we had intact dogs that had catheters implanted in the heart, and the drug would be given to the animals and we would then measure their pressures in the heart.  That cardiology experience in 1970, the summer between my first and second year of medical school, the Swan-Ganz catheter was being tested. I worked at Cedars that summer and was watching them do the various studies to show the value of the catheter. And so by the time I was kind of finishing up medical school, I'd already invested all this time as an undergraduate. And then a little bit when I was in medical school and I kind of understood the physiology of the heart, very exciting. So that's kind of where I was headed until we started my internship. And I don't know if any of you remembered Marty Cline, but he was the oncologist who moved from UCSF to Los Angeles to start our hem-onc division. And very exciting, a wonderful bedside teacher.   And so all of a sudden, I've never been exposed to oncology and this was very interesting. But at the same time, I was rotating through the CCU, and in came two full-arrest patients, one of whom was a campus cop who was very obese, had arrested at his desk in the police station. And we didn't have emergency vehicles to help people get on campus at that time. This was 1973 or 1974, something like that. And he came in full arrest, vegetable. And then another man had been going out of his apartment to walk his dog and go downstairs, and then all of a sudden his wife saw him out on the street being resuscitated by people. And he came in also in full arrest.   So those two experiences, having to deal with those patients, not being able to kind of comfort the families, to do anything about it. As well as taking care of patients in my old clinic who had very bad vascular disease. One man, extremely depressed with claudication and angina, all of a sudden made me feel, “Well, you know what? I'm not sure I really want to be a cardiologist. I'm not sure I like the acute arrest that I had to deal with and the families. And also, the fact that people were depressed and you couldn't really talk to them about how serious their disease was.” Whereas I had patients with advanced cancer who came in, who had equally difficult prognoses, but because of the way people understood cancer, you could really talk about the problems that they would be facing and the end-of-life concerns that they would have.  So it was all of those things together that made me say, “Hmm.” And then also, Pat, you'll appreciate this, being from Indiana, we were giving phase II platinum to advanced testicular cancer patients, and it was miraculous. And so I thought, “Oh my gosh, in my lifetime, maybe cancer is going to be cured! Heart disease, well, that's not going to happen.” So that was really the turning point.   Pat Loehrer: When many of us started, we were just hoping that we could get patients to live a little bit longer and improve the response rate. But you took a different tack. You really looked at treating the whole patient, not just the disease. That was really a novel approach at the time. What influenced you to take that step forward? Dr. Patricia Ganz: Well, it was actually my starting– it was thought to be in a hospice ward. It would turn out it was a Sepulveda VA, not the West LA VA, but in any case, we have two VAs that are affiliated with UCLA. And it was an intermediate care ward, and there was an idea that we would in fact put our cancer patients there who had to have inpatient chemotherapy so they wouldn't be in the acute setting as well as patients who needed to travel for radiation. Actually, the West LA VA had a hospice demonstration project. This is 1978. It's really the beginning of the hospice movement in England, then in Canada, Balfour Mount at Montreal and McGill was doing this. And so I was very much influenced by, number one, most of our patients didn't live very long. And if you were at a VA Hospital, as I was at that time, you were treating patients with advanced lung cancer, advanced colon cancer, advanced prostate cancer, other GI malignancies, and lung cancer, of course. So it was really the rare patient who you would treat for curative intent.  In fact, small cell lung cancer was so exciting to be treating in a particularly limited small cell. Again, I had a lot of people who survived. We gave them chemo, radiation, whole brain radiation, etc. So that was exciting. This was before cisplatin and others were used in the treatment of lung cancer. But really, as I began to develop this ward, which I kind of thought, “Well, why should we wait just to give all the goodies to somebody in the last few weeks of life here? I'm treating some patients for cure, they're getting radiation. Some of them are getting radiation and chemo for palliation.” But it was a mixed cancer ward. And it was wonderful because I had a team that would make rounds with me every week: a pharmacist, a physiatrist, a psychologist, a social worker, a dietitian. This was in 1978 or ‘79, and the nurses were wonderful. They were really available to the patients. It wasn't a busy acute ward. If they were in pain, they would get their medication as soon as possible. I gave methadone. It was before the days of some of the newer medications, but it was long-acting. I learned how to give that. We gave Dilaudid in between if necessary. And then we had Brompton solution, that was before there was really oral morphine.  And so the idea was all of these kinds of services should really be available to patients from the time of diagnosis until death. We never knew who was going to be leaving us the next few days or who was going to be living longer and receiving curative intent. We had support groups for the patients and their families. It was a wonderful infrastructure, something that I didn't actually have at UCLA, so it was a real luxury. And if you know the VA system, the rehabilitation services are wonderful. They had dental services for patients. We had mostly World War II veterans, some Korean, and for many of these individuals, they had worked and lived a good life, and then they were going to retire and then they got cancer. So this was kind of the sadness. And it was a suburban VA, so we had a lot of patients who were in the San Fernando Valley, had a lot of family support, and it was a wonderful opportunity for me to learn how to do good quality care for patients along the continuum.  Dave Johnson: How did you assemble this team? Or was it in place in part when you arrived, or what? Nobody was thinking about this multidisciplinary approach?  Dr. Patricia Ganz: I just designed it because these were kind of the elements that were in a hospice kind of program. And I actually worked with the visiting nurses and I was part of their boards and so forth. And UCLA didn't have any kind of hospice or palliative care program at that time. But because the VA infrastructure had these staff already, I didn't have to hire them, you didn't have to bill for anything. They just became part of the team. Plus there was a psychiatrist who I ultimately began doing research with. He hired a psychologist for the research project. And so there was kind of this infrastructure of interest in providing good supportive care to cancer patients. A wonderful social worker, a wonderful psychologist, and they all saw this patient population as very needy, deserving, and they were glad to be part of a team.  We didn't call it a hospice, we called it a palliative care unit. These were just regular staff members who, as part of their job, their mission was to serve that patient population and be available. I had never been exposed to a physiatrist before. I trained at UCLA, trained and did my residency and fellowship. We didn't have physiatry. For whatever reason, our former deans never thought it was an important physical medicine, it wasn't, and still isn't, part of our system. Pat Loehrer: Many decisions we make in terms of our careers are based on singular people. Your dad, maybe, suggesting going into medicine, but was there a patient that clicked with you that said, "Listen, I want to take this different direction?" Or was it just a collection of patients that you were seeing at the VA? Is there one that you can reflect back on? Dr. Patricia Ganz: I don't know if you all remember, but there was something called Consultation Liaison Psychiatry where, in that time, the psychiatrist really felt that they had to see medical patients because there were psychological and sometimes psychiatric problems that occurred on the medical ward, such as delirium. That was very common with patients who were very sick and very toxic, which was again due to the medical condition affecting the brain. And so I was exposed to these psychiatrists who were very behaviorally oriented when I was a resident and a fellow, and they often attended our team meetings in oncology on our service, they were on the transplant service, all those kinds of things. So they were kind of like right by our side.  And when I went to the VA, the psychiatry service there also had a couple of really excellent psychiatrists who, again, were more behaviorally focused. Again, you have to really remember, bless her heart, Jimmie Holland was wonderful as a psychiatrist. She and Barrie Cassileth were the kind of early people we would see at our meetings who were kind of on the leading edge of psychosocial oncology, but particularly, Jimmie was more in a psychiatric mode, and there was a lot of focus on coping. But the people that I began to work with were more behaviorally focused, and they were kind of interested in the impact of the disease and the treatment on the patient's life and, backwards, how could managing those kinds of problems affect the well-being of the patient. And this one psychiatrist, Richard Heinrich, had gotten money from the VA, had written a grant to do an intervention study with the oncology patients who I was serving to do a group intervention for the patients and their families. But, in order to even get this grant going, he hired a project manager who was a psychologist, a fresh graduate whose name was Anne Coscarelli, and her name was Cindie Schag at that time. But she said, "I don't know much about cancer. I've got to interview patients. I've got to understand what's going on." And they really, really showed me that, by talking to the patient, by understanding what they were experiencing, they could get a better handle on what they were dealing with and then, potentially, do interventions. So we have a wonderful paper if you want to look it up. It's called the “Karnofsky Performance Status Revisited.” It's in the second issue of JCO, which we published; I think it was 1984.  Dave Johnson: In the early 90s, you relocated back to UCLA. Why would you leave what sounds like the perfect situation to go back to a site that didn't have it? Dr. Patricia Ganz: Okay, over that 13 years that I was at the VA, I became Chief of the Division of Hem-Onc. We were actually combined with a county hospital. It was a wonderful training program, it was a wonderful patient population at both places. And we think that there are troubles in financing health care now, well, there were lots of problems then. Medicaid came and went. We had Reagan as our governor, then he became president, and there were a lot of problems with people being cared for. So it was great to be at the VA in the county, and I always felt privileged. I always had a practice at UCLA, which was a half-day practice, so I continued there, and I just felt great that I could practice the same wherever I was, whether it was in a public system, veteran system, or in the private system.   But what happened was, I took a sabbatical in Switzerland, '88 to '89. I worked with the Swiss International Breast Cancer Consortium group there, but it was really a time for me to take off and really learn about quality of life assessment, measurement, and so forth. When I came back, I basically said, "I want to make a difference. I want to do something at a bigger arena." If I just continue working where I am, it's kind of a midlife crisis. I was in my early 40s, and my office was in the San Fernando Valley at the VA, but my home was in West Los Angeles. One day I was in UCLA, one day I was at the VA, one day I was at the county, it was like, "Can I practice like this the next 20 years? I don't know that I can do this. And I really want to have some bigger impact.” So I went to Ellen Gritz who was my predecessor in my current position, and I was doing my NCI-funded research at UCLA still, and I said, “Ellen, I really would like to be able to do research full time. I really want to make a difference. Is there anything available? Do you know of anything?" And she said, "Well, you know, we're actually recruiting for a position that's joint between the School of Public Health and the Cancer Center. And oh my goodness, maybe I can compete for that, so that's what I did. And it was in what was then the department called Health Services, it's now called Health Policy and Management. I applied, I was competing against another person who I won't name, but I got the position and made that move.  But again, it was quite a transition because I had never done anything in public health, even though UCLA had a school of public health that was right adjacent to the medical school. I had had interactions with the former dean, Lester Breslow, who I actually took an elective with when I was a first-year medical student on Community Medicine. So it kind of had some inklings that, of what I was interested in. I had actually attendings in my medical clinic, Bob Brook, a very famous health policy researcher, Sheldon Greenfield. So I'd been exposed to a lot of these people and I kind of had the instinctive fundamentals, if you will, of that kind of research, but hadn't really been trained in it. And so it was a great opportunity for me to take that job and really learn a lot and teach with that.  And then took, part of my time was in the cancer center with funding from the core grant. And then, within a year of my taking this position, Ellen left and went to MD Anderson, so all of a sudden I became director of that whole population science research group. And it was in the early ‘90s, had to scramble to get funding, extramural funding. Everybody said to me, "How could you leave a nearly full-time position at the VA for a soft money position?" But, nevertheless, it worked out. And it was an exciting time to be able to go into a new career and really do things that were not only going to be in front and center beneficial to patients, but to a much larger group of patients and people around the world.  Pat Loehrer: Of all the work that you have done, what one or two things are you most proud of in terms of this field? Dr. Patricia Ganz: Recognizing the large number of people who are surviving cancer. And I think today we even have a more exciting part of that. I mean, clearly, many people are living long-term disease-free with and without sequelae of the disease. But we also have this new group of survivors who are living on chronic therapy. And I think the CML patients are kind of the poster children for this, being on imatinib or other newer, targeted agents over time, living with cancer under control, but not necessarily completely gone. And then melanoma with the immunotherapy, lung cancer, all of these diseases now being converted to ones that were really fatal, that are now enjoying long-term treatment.   But along with that, we all know, is the financial toxicity, the burdens, and even the ongoing symptoms that patients have. So the fact that we all call people survivors and think about people from the time of diagnosis as potentially being survivors, I think was very important. And I would say that, from the clinical side, that's been very important to me. But all of the work that I was able to do with the Institute of Medicine, now the National Academy of Medicine, the 2013 report that we wrote on was a revisit of Joe Simone's quality of care report, and to me was actually a very pivotal report. Because in 2013, it looked like our health care system was in crisis and the delivery of care. We're now actually doing a National Cancer Policy Forum ten-year follow-up of that report, and many of the things that we recommended, surprisingly, have been implemented and are working on. But the healthcare context now is so much more complicated.  Again, with the many diseases now becoming rare diseases, the cost of drugs, the huge disparities, even though we have access through the Affordable Care Act and so forth, there's still huge disparities in who gets care and treatment. And so we have so many challenges. So for me, being able to engage in the policy arena and have some impact, I think has been also very important to me. Dave Johnson: 20 years ago, the topic of survivorship was not that common within ASCO, and you led a 2004 task force to really strengthen that involvement by that organization, and you also were a founding member of the National Coalition for Cancer Survivorship. I wonder if you might reflect on those two activities for us for a moment. Dr. Patricia Ganz: In 1986, Fitzhugh Mullen, who in 1985 had written a really interesting special article for the New England Journal called "Seasons of Survivorship" - he was a young physician when he was found to have a mediastinal germ cell tumor and got very intensive chemotherapy and radiation therapy and survived that, but realized that there was no place in the healthcare system where he could turn to to get his questions answered, nor get the kind of medical care that was needed, and really wrote this very important article. He then, being somebody who was also kind of policy-oriented and wanting to change the world, and I would say this was a group of us who, I think went to college during the Vietnam era - so did Fitz - and we were all kind of restless, trying to see how we could make a difference in the world and where it was going.   And so he had this vision that he was going to almost develop an army of survivors around the country who were going to stand up and have their voices heard about what was going on. Of course, most people didn't even know they were a survivor. They had cancer treatment, but they didn't think about themselves as a survivor. And so he decided to get some people together in Albuquerque, New Mexico, through a support group that he had worked with when he was in the Indian Health Service in New Mexico. And there were various people from the American Cancer Society, from other support organizations, social workers, and a couple of us who are physicians who came to this meeting, some Hodgkin survivors who had been treated at Stanford and were now, including a lawyer, who were starting to do long term late effects work. And we gathered together, and it was a day and a half, really, just kind of trying to figure out how could a movement or anything get oriented to try and help patients move forward.  So that's how this was founded. And they passed the hat. I put in a check for $100, and that was probably a lot of money at that time, but I thought, well, this is a good investment. I'll help this organization get started. And that was the start. And they kind of ran it out of Living Beyond Cancer in Albuquerque for a few years. But then Fitz, who was in the Washington, DC. area decided they weren't going to be able to get organizations all over the country organized to do this, and they were going to have to do some lobbying. So Ellen Stovall, who was a Hodgkins survivor living in the Washington area, beginning to do policy work in this area, then became the executive director and took the organization forward for many years and championed this, got the Office of Cancer Survivors established at the NCI in the 1990s, and really did a lot of other wonderful work, including a lot of the work at the Institute of Medicine. She was very involved with the first Quality of Care report and then ultimately the survivorship report, the Lost and Transition report in 2005, 2006, I was on that committee. So that was really how things were evolving.  And by that time, I was also on the ASCO board, 2003 to 2006. And so all of these things were kind of coming together. We had 10 million survivors. That was kind of an important note and a lot of diseases now - lymphoma, breast cancer, multi-agent therapy had certain benefits, but obviously toxicities. We lived through the horrible time of high-dose chemotherapy and transplant for breast cancer in the ‘90s, which was a problem, but we saw a lot of toxicities after that. And so there were people living after cancer who now had sequelae, and the children obviously had been leading the way in terms of the large number of childhood cancer survivors. So this was this idea that the children were kind of the canary in the coal mine. We saw them living 20, 30 years later after their cancer diagnosis, and we were now beginning to see adults living 10, 15, 20 years later, and we needed to think about these long-term and late effects for them as well. Dave Johnson: I'm glad you mentioned Fitz's article in the New England Journal that still resonates today, and if listeners have not read it, "Seasons of Survivorship" is a worthwhile five-minute read.  What do you think the most pressing issues and challenges in cancer survivorship care today?  Dr. Patricia Ganz: Many people are cured with very little impact. You can think of somebody with T1 breast cancer maybe needing endocrine therapy for five years, and lumpectomy radiation. That person's probably not going to have a lot that they're going to be worried about. But if they're a young breast cancer patient, say they're 35 or 40, you're going to get five years of ovarian suppression therapy. You're going to be put into acute menopause. You're going to lose bone density. You're going to have cardiac risk acceleration. You may have cognitive changes. You may have also problems with cognitive decline later. I mean, all of these things, the more intense treatments are associated, what we're really thinking about is accelerated aging. And so a lot of what I've been studying the last 20-25 years in terms of fatigue and cognitive difficulties are related to neuroinflammation and what happens when somebody has intensive systemic therapy and that accelerated process that's, again, not everyone, but small numbers of patients, could be 10-15-20%. So I worry a lot about the young patients. So I've been very focused on the young adult population who are treated intensively for lymphoma, leukemia, and breast. And that's, I think, something that we need to be looking out for.  The other thing is with the newer therapies, whether it's immunotherapy or some of the targeted therapies, we just don't know what the late effects are going to be. Where we're very schooled now in what the late effects of radiation, chemo, and surgery could be for patients, we just don't know. And another wonderful part of my career has been to be able to do quality-of-life studies within the Clinical Trials Network. I've been affiliated with NSABP, I was SWOG previously, but NSABP is now NRG Oncology doing patient-reported outcomes and looking at long-term outcomes in clinical trials. And I think we're going to need this for all of these new agents because we have no idea what the long-term toxicities are going to be. And even though it's amazing to have people surviving where they wouldn't have been, we don't know what the off-target long-term effects might be. So that's a real challenge right now for survivorship.  And the primary care doctors who we would want to really be there to orchestrate the coordinated care for patients to specialists, they are a vanishing breed. You could read the New England Journal that I just read about the challenges of the primary care physician right now and the overfilled inbox and low level of esteem that they're given in health systems. Where are we going to take care of people who really shouldn't be still seeing the oncologist? The oncologist is going to be overburdened with new patients because of the aging of the population and the many new diagnoses. So this is our new crisis, and that's why I'm very interested in what we're going to be looking at in terms of a ten-year follow-up report to the 2013 IOM report. Dave Johnson: The industry-based trials now are actually looking at longer-term treatment. And the trials in which interest is cancer, we cut it down from two years of therapy down to nine weeks of therapy, looking at minimizing therapy. Those are difficult trials to do in this climate today, whereas the industry would just as soon have patients on for three to five years worth of therapy as opposed to three to five months. Talk a little about those pressures and what we should be doing as a society to investigate those kinds of therapies and minimizing treatments. Dr. Patricia Ganz: Minimizing treatments, this is the place where the government has to be, because we will not be able to do these de-escalation studies. Otherwise, there will be countries like the UK, they will be able to do these studies, or other countries that have national health systems where they have a dual purpose, if you will, in terms of both financing health care and also doing good science. But I think, as I've seen it, we have a couple of de-escalation trials for breast cancer now in NRG Oncology, which is, again, I think, the role that the NCTN needs to be playing. But it's difficult for patients. We all know that patients come in several breeds, ones who want everything, even if there's a 1% difference in benefit, and others who, “Gee, only 1 out of 100 are going to benefit? I don't want that.” I think that's also the challenge. And people don't want to be denied things, but it's terrible to watch people go through very prolonged treatments when we don't know that they really need it for so long.  Dave Johnson: Pat and I both like to read. I'm wondering if there's something you've read recently that you could recommend to us. Dr. Patricia Ganz: It's called A Gentleman in Moscow by Amor Towles. I do like to read historical fiction. This one is about a count at the time of the Bolshevik Revolution who then gets imprisoned in a hotel in Moscow and how constrained his life becomes, but how enriched it is and follows him over really a 50-year period of time and what was happening in the Soviet Union during that time. And of course, with the war in Ukraine going on, very interesting. Of course, I knew the history, but when you see it through the drama of a personal story, which is fictional, obviously it was so interesting.   My husband escaped from Czechoslovakia. He left in '66, so I had exposure to his family and what it was like for them living under communism. So a lot of that was interesting to me as well.  Dave Johnson: Thank you for joining us. It's been a wonderful interview and you're to be congratulated on your accomplishments and the influence you've had on the oncology world.  We also want to thank our listeners of Oncology, Etc., and ASCO Educational Podcast where we will talk about oncology, medicine and beyond. So if you have an idea for a topic or a guest you'd like us to interview, by all means, email us at education@asco.org. To stay up to date with the latest episodes and explore other ASCO educational content, please visit education.asco.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.    

Was machst Du, wenn die Zeit zu knapp fürs Training ist? Der vermutlich größte Fehler ist, in ein "Ganz-oder-Garnicht"-Denken zu verfallen. Die Erfahrung zeigt, dass fitte Menschen für solche Situationen einen "Plan B" parat haben, der auch kleinere Zeitlücken so nutzt, dass Du Dir guttust und dranbleibst. Du erfährst: welche kleinen Anpassungen an Deinem Trainingsplan Zeit zu sparen, ohne dass Du dabei auf Effektivität verzichtest, wie Du mit längeren (unvermeidbaren) Trainingspausen umgehst, wann sie "schaden" und wann nicht, wie Du den perfekten (aber nicht umsetzbaren) Trainingsplan drastisch verkürzt, so dass er immer noch "gut genug" ist, und vieles mehr ... Denn, Hand aufs Herz, gerade in stressigen Phasen wäre es doch jammerschade, auf das wunderbare Gefühl nach dem Training zu verzichten, oder? ________

Wir sind in der finalen Folge des Summer-Specials angelangt. Heute mit einem Gespräch zwischen Curse und Jutta vom "Einfach ganz leben" Podcast. Entstanden ist ein bunt gemischtes Gespräch über gute Fragen, das Leben an sich, Coaching und Meditation. Über die verschiedenen Wege sich auszudrücken, und wie die richtigen Fragen unserem Leben neue Impulse oder eine neue Richtung geben können. Viel Spaß beim lauschen. Einfach ganz Leben Podcast: https://www.einfachganzleben.de/podcast https://www.einfachganzleben.de/ Podcast Folge "Die neue Dankbarkeit": https://open.spotify.com/episode/5zO98exdwYc7W0SmA9UgKc?si=88a3eed6dddf47ce www.curse.de www.instagram.com/cursezeit www.facebook.com/curseofficial

¡Qué decepción! El que es uno de los coches más populares de la historia, el que para el Tercer Reich iba a ser el coche de pueblo, el modelo que es un verdadero referente, el modelo diseñado por el genial Ferdinand Porsche… resulta que es una copia. En este modelo, Ferdinand Porsche no inventó nada. Y Hitler tuvo mucho que ver. ¿No os lo creéis? No lo digo yo… lo reconoce la propia VW… ¡Cuánto me ha costado hacer este guion! He investigado muchas horas, en ratos libres, en fines de semana, curioseado en libros, revistas, páginas Web y documentales, con la ayuda de Rodrigo, que pasa horas buscando imágenes e información… Contaremos como Ferdinand Porsche no inventó nada de su famoso Escarabajo, sino que copió un diseño del periodista y diseñador judío Joseff Ganz al que la Alemania nazi y post nazi le hizo la vida imposible y que también copió de la marca checa Tatra, de los T77 y T97, un diseño brillante de los ingenieros Ledwinka y Jaray. Ganz, el gran olvidado. En 1933, es decir, 5 años antes de que Adolf Hitler anunciase el proyecto de su “coche para el pueblo”, su Volkswagen, el ingeniero alemán Josef Ganz ya había diseñado y construido el Standard Superior Type I. Antes había realizado otros brillantes diseños de coche asequibles y modernos. Según Ganz los coches alemanes de la época eran “anticuados e inseguros”, incluso hizo un detallado estudio de accidentes para llegar a la conclusión que era verdaderas “cajas” por su forma, de “muertos” por su peligrosidad. ¿Qué tiene de particular este coche? Bueno, visto por fuera una cosa salta a la vista: Su diseño es muy parecido al de un VW más “antiguo”. Pero es que en su interior su chasis separado, su motor trasero y sus suspensiones oscilantes, con del mismo tipo o muy parecido a las que utilizó el VW Escarabajo de supuesto diseño Porsche. ¿Cuál era el mayor problema de Ganz? Un problema muy grave y muy serio en la Alemania Nazi: Era judío. Joseff Ganz, que no era nada tonto, había patentado muchas de las soluciones de su Standard e incluso Ferdinand Porsche llamó la atención de este “pequeño detalle” al propio Hitler, según nos cuenta el historiador holandés Paul Schilperoord, verdadero experto en el tema y que ha tenido acceso a mucha y detallada documentación original por avatares de la historia largos de contar. ¿Cómo solucionó este anuncia la Alemania Nazi? Sencillo: Retiraron la nacionalidad a Joseff Ganz que, al no ser alemán, que para el III Reich era lo mismo que no existir, no podría registrar patentes… problema resuelto. ¿Os parece una solución radical? Te adelanto que, en este historia, hay otras peores. Josef Ganz fue desprovisto de su nacionalidad alemana y perseguido por el régimen. Huyó a Suiza, donde quiso hacer el “coche del pueblo suizo”, pero el comienzo de la Segunda Guerra Mundial echo por tierra el proyecto. Al acabar la guerra fueron los ingleses los que pusieron en marcha la fábrica de VW y fue un enorme éxito. Pero VW y el gobierno alemán no reconocieron el mérito de Ganz. El entonces presidente de la compañía Nordhoff envió una carta para ofrecer a Ganz, en esos momentos retirado y solo en Australia, un trabajo y o una pequeña pensión. Parece ser que la pensión nunca la cobró y murió antes de poder regresar a Alemania. Pero en el museo de VW, en una sala llamada “Rémy Markowitsch” se hace referencia a los modelos “inspiradores” del VW, entre los que aparecen el Standard Superior de Ganz y los Tatra T77 y T97. Y vamos con la segunda historia. Adolf Hitler en uno de sus encendidos discursos, habla de que Alemania va a motorizar a todos los alemanes con su “Coche del Pueblo” su Volkswagen, que inicialmente se llamaba KDF-Wagen, o sea, Kraft durch Freude, que traducido seria “Fuerza a través de la alegría”. Hitler, para este proyecto, escoge a su ingeniero de confianza que era Ferdinand Porsche, que llevaba tiempo trabajando en un coche que el propio Porsche definía como “el coche para todos” … al menos en el planteamiento, estaban de acuerdo. Pero Hitler quería el coche ya… y ya es ya. Solo dos años después se presentaba el primero prototipo del Escarabajo, conocido como Tipo 60. A partir de este prototipo el Escarabajo lo fabrica… Mercedes-Benz. Sí, el Mercedes 130. ¿Cómo pudo Ferdinand Porsche ser tan rápido? ¿Copiando a Ganz? Sí, pero no solo a Ganz… Porque pocos meses después de la presentación del VW, el que luego acabaría llamándose Volkswagen Escarabajo o Beetle, entre otros muchos nombres, los ingenieros Ledwinka y Jaray demandan a Volkswagen y a Ferdinand Porsche por plagiar el diseño de su Tatra T97. No andaban desencaminados, porque el motor del Tatra era… un 4 cilindros Bóxer… Por si la estética, el motor y las parecidas o idénticas soluciones técnicas no bastasen en el libro “Car Wars” Adolf Hitler dice que “el Tatra es el tipo de coche que quiero en mis carreteras”. Esta demanda preocupaba mucho a Ferdinand Porsche, seguramente más por prestigio que por otra cosa, y se pone en contacto con Adolf Hitler quien le tranquiliza diciendo que “solucionaría a su modo la cuestión Tatra-Volkswagen”. ¿Y cuál era ese modo? Muy sencillo, ese mismo año Alemania invade Checoslovaquia y reconvierte la factoría de Tatra en una fábrica de armamento militar. Confisca y destruye unos 500 Tatra modelo T97 para que este tema pasase al olvido… pero no pasa. ¿Por qué? Porque al finalizar la Segunda Guerra Mundial, Tatra retoma las acciones legales contra Volkswagen y Ferdinand Porsche. ¿VW era culpable o inocente? No se sabe, porque no hubo juicio: Se llegó a un acuerdo extrajudicial por el cual VW indemniza a Tatra con tres millones de marcos alemanes. Para mí una forma de reconocer que eran culpables… pero no la única. Porque en los primeros episodios legales que enfrentaron a Tatra con el propio Ferdinand Porsche este dijo una frase para la historia, donde reconocería “haber observado de vez en cuando sobre el hombro de Ledwinka”. Blanco y en botella, ¡leche! No hace falta que os diga que con Adolf Hitler no había medias tintas: O estabas con él o estabas contra él. Muchas marcas de coches alemanas, en general toda la industria, apoyo al nacismo… pero la pregunta es, ¿les quedaba otra opción? Por eso quería revindicar a Ferdinand Porsche, genial ingeniero que con solo 23 años diseño el considerado por casi todos, el primer híbrido de la historia, el Lohner-Porsche Mixte Hybrid. Hizo multitud de diseños muy innovadores, tan largo de contar que merece otro vídeo… Coche del día. ¡Me encanta Tatra! Y me encanta el Tatra T97 que creo que se merece un lugar en lo historia que nunca ha conseguido. Realmente viendo este coche junto con el Escarabajo, resulta evidente su parecido…

Jason Ganz and Laurence Kessler join the show for the first episode of Season 3 where we preview the 2023 upcoming College Football season. The highlights include UGA's road to a 3-peat, Carson Beck in as QB1, Alabama's chances of getting back to the playoffs, Hugh Freeze in at Aubrun,Conference Realignment, Coach Prime in Colorado, and current state of NIL. Finally, we give our predictions for who will reach the Final 4, who will win the Heisman and Larry's Loser aka the Sucker Bet. We are also proud to announce our new partnership with www.dawgnation.com where each week the J. Stein Law Firm and Sports ‘N Torts will sponsor UGA's Injury Report and the Player of the Game. As always, this episode is powered by the J. Stein Law Firm – a personal injury law firm in Atlanta, Ga – www.jsteinlawfirm.com.

Spontan einen Bus klauen und eine Runde durch die Stadt drehen - in Fürstenwalde (LOS) hat sich ein 23-Jähriger wahrscheinlich gleich zwei Mal Linienbusse geklärt und ziellos Runden gedreht. Bitte nicht nachmachen - aber ganz ehrlich, solche oder ähnliche Aktionen habt ihr alle schon gemacht! Ganz egal ob "kurz ausgeliehene" Autos oder Traktoren, Arschgeweih-Tattoo im Vollrausch oder den Nachbarn den Briefkasten mit Bauschaum vollgemacht - erzählt Bruno Dietel heute Abend ab 22 Uhr von euren kleinen und großen Fehltritten.

Jacko kommt geistig erholt und körperlich zerstört aus dem Retreat und auch Sam ist körperlich angeschlagen, denn trotz des erholsamen Campings, gab es keine erholsame Stuhlgang-Situation. Ganz im Gegenteil. In dieser Folge gehts neben körperlichen Herausforderungen außerdem um prägende Blitzer-Erinnerungen und stressige Bachelor-Arbeiten. Zum Prokratsinations-Ted-Talk: https://www.ted.com/talks/tim_urban_inside_the_mind_of_a_master_procrastinator http://instagram.com/jackowusch http://instagram.com/samykee Mails an: jackundsampodcast@gmail.com https://jackundsam.com (unser edler Online-Shop) *werbelink Werbung: Alle Infos, Angebote und Codes unserer Werbepartner findet ihr hier: https://linktr.ee/jackundsampodcast

Wie ist eine friedliche selbstbestimmte Geburt in einer großen Klinik möglich, in der eher pathologische Geburtsverläufe Alltag sind und von maximal invasiven Geburten ausgegangen wird? Christina berichtet begeistert von ihrer schönen Geburtserfahrung in Hypnose und ihrer gewissenhaften Vorbereitung mit meiner Methode. Als ziemlich ängstlicher Mensch gab ihr ihre Klinik-Wahl mehr Sicherheit und mit den geburtsvorbereitenden Hypnosen gewann sie immer mehr Zuversicht für ihre Geburt. In diesem Interview erfährst du, wie - Hypnose sehr gut funktioniert, ohne spirituell zu sein - du auch nach der Geburt deine Akkus mit Hypnose aufladen kannst - sehr es die Gebärende stärkt, wenn ihre mentale Vorbereitung positiv im Kreißsaal aufgenommen wird - dich meine Atemtechnik bei der Geburt empowern kann - du mit „Störungen“ im Klinikalltag umgehen kannst Unser Gespräch kannst du dir wieder sehr gerne auf YouTube ansehen und über einen Daumen nach oben und die aktivierte Glocke freue ich mich riesig https://youtu.be/8Ovlvp_gQiA Wir spielen sogar kurz Wunschkonzert in Form einer Frage, die vielleicht schon ganz bald jeder Schwangeren gestellt wird: „WO machst du denn deine mentale Geburtsvorbereitung?“ Hierfür ist es natürlich wichtig, dass in hebammengeleiteten Geburtsvorbereitungskursen auch die mentale Geburtsvorbereitung angesprochen wird, damit mehr Schwangere überhaupt davon erfahren. Denn, wie Christinas Geburt eindrücklich zeigt, ist so eine friedliche Geburt auch ein unglaublich wertvolles Geschenk für das geburtsbegleitende Personal. Schreibe mir gerne auf Instagram unter dem Post zur heutigen Podcastfolge, ob in deinem „normalen“ Geburtsvorbereitungskurs auch über mentale Vorbereitungsmethoden informiert wurde https://www.instagram.com/die.friedliche.geburt/. Kennst du schon die beiden tollen Geburtsberichte in diesen Podcastfolgen? https://die-friedliche-geburt.de/2022/12/18/266-eine-sehr-lange-traumgeburt-in-wien-interview-mit-judith-und-yannick/ https://die-friedliche-geburt.de/2022/06/12/239-traumgeburt-in-einer-level-1-klinik-interview-mit-laura-und-julian/ Möchtest du dich vielleicht von mir bei deiner Geburtsvorbereitung unterstützen lassen? Gerne kannst du mal kostenfrei und ohne Abofalle für 14 Tage in meinen Online-Kurs reinschnuppern https://die-friedliche-geburt.de/schnupperzugang/ Ganz viel Freude und Zuversicht mit dieser Podcastfolge! Alles Liebe Deine Kristin

Immer häufiger werden in politischen Debatten Andersdenkende massiv ausgegrenzt. Ganz zu schweigen von der seit Jahren immer schlimmer werdenden „Cancel-Culture“, die auf die berufliche und soziale Vernichtung Andersdenkender aus ist. Solchen Vorgängen gemeinsam ist ein Denken, das dem „Anderen“ kein Recht mehr auf eine Meinung zugesteht, die von der Mehrheitsmeinung oder der Meinung der ElitenWeiterlesen

Was, wenn Du das, was Du als Deine Persönlichkeit bezeichnest, NICHT bist? Ich meine so ganz pragmatisch als Mensch. Was, wenn „typische Charakterzüge“ und „Eigenschaften“ Dich (als Mensch) in keinster Weise beschreiben? Diese Dich mittlerweile eher ausbremsen, als dass sie (noch) förderlich sind? Weil Du noch etwas über Dich glaubst, was Dir in der Rotstift-Zeit (Erziehung) über Dich, Deine Talente und Fähigkeiten, über Deine Größe, Deinen Wert und Deine Möglichkeiten erzählt wurde? Was, wenn Du Dich selbst noch immer deckelst, weil Du noch nie fühlend hinterfragt hast, ob Du wirklich, wirklich die Stille, Leise, Zurückhaltende bist? oder das Sensibelchen, der Aufbrausende, Ungeduldige? oder die schon immer Chaotische, Unordentliche, Unstrukturierte? oder der Faule, besonders Fleißige (bis zum Umfallen)? oder die Bescheidene im Hintergrund (sich den A… für alle anderen aufreißend) oder der nette, angepasste, 24/7 strahlende Everybody's Darling? oder die ehrgeizige Macherin, der knallharte Emotionslose? usw.usf. Was, wenn das alles nur „Labels“ sind, die wie eine dicke, träge Schicht Deinen wahren Wesenskern überlagern? Und es dran ist, Dich selbst zu fragen, ob Du überhaupt noch Lust hast auf diese Rollen? -- In dieser Episode geht's um Deine Persönlichkeit, um typische Charakterzüge, Eigenschaften und Merkmale. Du wirst lernen, wie das, was wir als „unsere Persönlichkeit“ beschreiben, entsteht. Und Du wirst eine tiefe Ahnung davon bekommen, dass Du sehr wahrscheinlich ganz anders bist, als Du bisher glaubtest.

Welcome Back aus der Sommerpause - Wir haben euch vermisst! Diesmal führt uns das erste Date von Lisa an einen suuuper romantischen Ort: ins Möbelhaus. Ganz normal, oder? Da trifft sie Anna und David um zu schauen, ob's zwischen praktischen Küchen und Kissenbezügen funkt. Warum die drei danach die Polizei rufen müssen und was Hamburger mit ihrer Story zu tun haben, hört ihr in dieser Folge von 1.000 erste Dates. Ihr möchtet mehr über unsere Werbepartner erfahren? Hier findet ihr Infos & Rabatte: https://linktr.ee/1000ersteDates

Der russische Söldnerchef Prigoschin ist offenbar bei einem Flugzeugabsturz nördlich von Moskau ums Leben gekommen. Die Wagner-Gruppe bestätigte den Tod Prigoschins und spricht von einem Abschuss des Privatjets. Muss man davon ausgehen, dass das kein Unfall war? Das kommentiert heute Markus Feldenkirchen vom Spiegel. Außerdem: Am Montag fängt die Schule wieder an und es fehlen immer noch rund 1400 Lehrer*Innen. Wie es weiter gehen soll an Berlins Schulen, fragen Julia Menger und Kerstin Hermes Bildungssenatorin Katharina Günther-Wünsch von der CDU. Und wir feiern die neuen Trends von der Gamescom.

Alex Ganz

Es ist ein heißer Tag. Juri freut sich schon auf den Kindergarten. Ganz alleine packt er alles zusammen und macht sich fertig. Er hat sich sogar schon mit Sonnencreme eingeschmiert. Da erfährt er, dass gar kein Kindergarten ist, weil Ferien sind. (Eine Geschichte von Renus Berbig, erzählt von Lisa Wagner)

Es gibt viele besondere Tage, zum Beispiel den internationalen Tag der Blockflöte oder den Weltkuscheltag. Ralph und Clarissa haben heute auch einen besonderen Tag: den Internationalen Gönndireis Tag. Was sich dahinter verbirgt? Ganz viel Eis! Und die Antworten auf fünf spannende Fragen…

Im heutigen Podcast redet Wolfram Zurhorst über eine der großen Gefahren für Langzeitbeziehungen. In der Vergangenheit lebten Paare oft viele Jahre in einem Status Quo und einem gefüllten Alltagsleben, ohne tiefere emotionale Ebenen je miteinander wirklich zu berühren. Wenn dann irgendwann eine ernste Krise auftaucht oder die Beziehung immer schaler wird, dann neigen viele einfach dazu, zu früh das Handtuch zu werfen, statt gemeinsam durch einen längst überfälligen Entwicklungsprozess zu gehen. Dabei gäbe es eine gute Alternative zur Trennung.    Hier geht es in unsere Coachingwelt: https://www.zurhorstundzurhorst.com/coachingwelt/   Falls Sie Fragen haben, schreiben Sie uns gerne eine E-Mail: coaching@zurhorstundzurhorst.com _________________________    Zurhorst auf Facebook: @zurhorstundzurhorst Zurhorst auf Instagram: @zurhorstundzurhorst Coachinganfragen: coaching@zurhorstundzurhorst.com

Neubig, Magdalenawww.deutschlandfunk.de, Deutschland heuteDirekter Link zur Audiodatei

Wenn ihr diese Folge hört, verfügt unser Podcast bereits über eine Million Downloads – ja, eine Million. Unglaublich oder?Und aus diesem Anlass haben wir etwas organisiert, was es noch nie gab: Alle aktuellen Hosts von „Ganz offen gesagt“ sitzen in einem Raum. Wir sprechen in dieser Episode über die Bedeutung der Transparenzpassage, wer unsere Lieblingsgäste und -folgen waren, was unser Format von anderen Interview-Formaten unterscheidet und welche Gäste wir uns für die noch kommenden Folgen wünschen.Und noch ein Spoiler: Diese Spezialfolge endet spektakulär, wenn ihr also wissen wollt wieso einer der Hosts bei der Aufnahme großer Gefahr ausgesetzt war, hört diese Folge unbedingt bis zum Ende…Links zur Folge:Die Top-Ten:1 – Georg Renner/Manfred Matzka2 – Julia Ortner/Peter Filzmaier3 – Julia Ortner/Barbara Kaufmann4 – Julia Ortner/Nicole Schöndorfer5 – Stefan Lassnig/Gerhard Mangottt6 – Julia Ortner/Hans-Peter Siebenhaar7 – Jonas Vogt/Matthias Strolz8 – Jonas Vogt/Paul Ronzheimer9 – Stefan Lassnig/Christian Nusser10 – Solmaz Khorsand/Franziska Schutzbach 

Wenn es um das Thema Geburt geht, wird es manchmal fast ideologisch. Manchen kann es gar nicht natürlich genug sein, andere möchten möglichst viel medizinische Unterstützung oder planen einen Wunschkaiserschnitt. Wie sollte eine Geburt aussehen, damit das Risiko für Mutter und Kind möglichst gering ist? // Alle Quellen und weitere Spezials findest du hier: https://www.quarks.de/daily-quarks-spezial/ Von Christiane Tovar.

Außerdem: Müssen wir aufhören Shrimps zu essen? (15:10) // Mehr spannende Themen, wissenschaftlich eingeordnet findet ihr hier: www.quarks.de // Kritik, Fragen? Schreibt uns! --> quarksdaily@wdr.de Von Yvonne Strüwing.

Ferienzeit ist potenziell eine Zeit, in der man sich vorübergehend vom steten Strom der Nachrichten, der Meinungsmache und der Diffamierungen Andersdenkender abschneiden könnte. Ist das empfehlenswert? Ja und nein. Von Tobias Riegel. Dieser Beitrag ist auch als Audio-Podcast verfügbar. Propaganda wirkt. Sie wirkt auch auf medienkritische Menschen, zumindest unterschwellig, wie die NachDenkSeitenWeiterlesen

Minna sitzt am Meer. Ganz vorne am Strand, die Füße ausgestreckt, so dass die Wellen sie anstupsen. Als das plastikflaschengroße U-Boot von Nautilus II genau dort strandet ist guter Rat gefragt, denn Nautilus II muss weiter nach London und zwar fix! Aber woher ein neues Boot nehmen? (Eine Geschichte von Kathi Roman, erzählt von Axel Milberg)

Meine letzten 24 Stunden waren ganz schön heftig. Und weil viele von euch für das heutige Q&A geschrieben haben, dass sie meine Alltagsgeschichten mit dem Mucki, der Autist ist, super spannend und bereichernd finden, dachte ich mir, erzähle ich euch doch einfach mal, was bei uns los war. In der Folge gibt's aber natürlich noch mehr Antworten! Zum Beispiel auf die Frage, ob wir WIRKLICH kein 3. Kind mehr wollen, was ich am liebsten Esse und wo eigentlich die Opas bei uns sind. Ganz viel Spaß mit der Folge und ihr wisst ja: Gönnt euch was

Wooooow, unsere 100. Folge ist im Kasten. Und wieder eine besondere! Julie hat unseren neuen Blogbeitrag aufgenommen, damit ihr ihn euch ganz entspannt anhören könnt. Diesmal geht es um das Thema: Bewerbung und Benotung von Kindern. Den Blogbeitrag findet ihr ebenfalls zum lesen auf unserem Blog www.solandpepper.com Hinterlasst uns wie immer gerne eine Bewerbung auf Spotify! Ganz viel Spaß!

Eine lupenreine Trennung bei kommunalen Sachentscheidungen könne niemand durchhalten, sagt der sächsische Ministerpräsident. Was er nicht sagt: Es gibt Alternativen zum „Wir sind dagegen, weil die AfD dafür ist“. *** Statt 4 Wochen können Sie jetzt 6 Wochen das digitale Handelsblatt für 1 € lesen. Zusätzlich verlosen wir unter allen Teilnehmenden zehn Amazon Gutscheine im Wert von je 500 €. Sichern Sie sich jetzt unser Sommerangebot – unter www.handelsblatt.com/sommer-special Helfen Sie uns, unsere Podcasts weiter zu verbessern. Ihre Meinung ist uns wichtig: www.handelsblatt.com/zufriedenheit [Mehr über die Angebote unserer Werbepartner:innen finden Sie HIER](https://cmk.handelsblatt.com/cms/articles/15597/anzeige/podcast-werbepartnerinnen/hier-gibt-s-weitere-infos-zu-den-angeboten-unserer-werbepartner-innen)

Max Clarke aus Brooklyn lässt seinem wunderschönen, 17 Songs starken Album «Nobody Lives Here Anymore» eine neue Platte mit nur knapp halb so vielen Songs folgen... und leider klingt das Meiste davon auch nur halb so abwechslungsreich wie das Songmaterial seiner facettenreichen letzten Platte. Hmpf. Ganz für die Tonne ist Cut Worms' drittes, selbstbetiteltes Album aber nicht: «Don't Fade Out» ist definitiv einer der schönsten Country-Schunkel-Songs des Jahres. Und die restlichen Stand-outs? Die gibt's in der heutigen Sendung. Aus dem Sounds!-Archiv: * Cut Worms «Nobody Lives Here Anymore»: Zeitloser Sound aus Brooklyn